Vicore Pharma Holding AB (publ) (VICO) - Total Liabilities

Latest as of December 2025: Skr124.16 Million SEK ≈ $13.36 Million USD

Based on the latest financial reports, Vicore Pharma Holding AB (publ) (VICO) has total liabilities worth Skr124.16 Million SEK (≈ $13.36 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore VICO operating cash flow to assess how effectively this company generates cash.

Vicore Pharma Holding AB (publ) - Total Liabilities Trend (2012–2025)

This chart illustrates how Vicore Pharma Holding AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Check Vicore Pharma Holding AB (publ) asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Vicore Pharma Holding AB (publ) Competitors by Total Liabilities

The table below lists competitors of Vicore Pharma Holding AB (publ) ranked by their total liabilities.

Company	Country	Total Liabilities
Vinacafe Bien Hoa JSC VN:VCF	Vietnam	₫588.19 Billion
Pss Co Ltd TW:6914	Taiwan	NT$6.63 Billion
Ningbo Xianfeng New Material SHE:300163	China	CN¥53.46 Million
Sword Group S.E PA:SWP	France	€218.94 Million
Advancetek Enterprise Co Ltd TW:1442	Taiwan	NT$6.29 Billion
Trastor Real Estate Investment Company SA AT:TRASTOR	Greece	€452.48 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Vicore Pharma Holding AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Vicore Pharma Holding AB (publ).

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vicore Pharma Holding AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vicore Pharma Holding AB (publ) (2012–2025)

The table below shows the annual total liabilities of Vicore Pharma Holding AB (publ) from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr124.16 Million ≈ $13.36 Million	+68.28%
2024-12-31	Skr73.78 Million ≈ $7.94 Million	+73.81%
2023-12-31	Skr42.45 Million ≈ $4.57 Million	-13.23%
2022-12-31	Skr48.92 Million ≈ $5.27 Million	-27.90%
2021-12-31	Skr67.85 Million ≈ $7.30 Million	+30.48%
2020-12-31	Skr52.00 Million ≈ $5.60 Million	+166.53%
2019-12-31	Skr19.51 Million ≈ $2.10 Million	+20.71%
2018-12-31	Skr16.16 Million ≈ $1.74 Million	+146.44%
2017-12-31	Skr6.56 Million ≈ $705.85K	+8.36%
2016-12-31	Skr6.05 Million ≈ $651.40K	-17.03%
2015-12-31	Skr7.29 Million ≈ $785.06K	+28.61%
2014-12-31	Skr5.67 Million ≈ $610.40K	-48.30%
2013-12-31	Skr10.97 Million ≈ $1.18 Million	+90651.92%
2012-12-31	Skr12.09K ≈ $1.30K	--

About Vicore Pharma Holding AB (publ)

ST:VICO Sweden Biotechnology

Market Cap

$302.36 Million

Skr2.81 Billion SEK

Market Cap Rank

#14932 Global

#234 in Sweden

Share Price

Skr9.98

Change (1 day)

-0.40%

52-Week Range

Skr7.35 - Skr13.34

All Time High

Skr37.60